4//SEC Filing
Maunsell Farris Maryanne 4
Accession 0001127602-25-017102
CIK 0000313143other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:49 PM ET
Size
5.1 KB
Accession
0001127602-25-017102
Insider Transaction Report
Form 4
Maunsell Farris Maryanne
VP, Chief Accounting Officer
Transactions
- Award
Common Stock
2025-06-05+2,662→ 4,478 total
Footnotes (3)
- [F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. Two-thirds of the RSUs vest in two equal annual installments beginning on the first anniversary of the date of grant and one-third of the RSUs vests based on the Issuer's common stock price at the end of a two-year performance period.
- [F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
- [F3]This number includes unvested RSUs previously reported.
Documents
Issuer
HAEMONETICS CORP
CIK 0000313143
Entity typeother
Related Parties
1- filerCIK 0001950052
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:49 PM ET
- Size
- 5.1 KB